RELATIONSHIP BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Beauchemin, C. [1 ]
Johnston, J. B. [2 ]
Lapierre, M. [1 ]
Aissa, F. [3 ]
Lachaine, J. [1 ]
机构：
[1] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
[2] Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada
[3] Lundbeck Canada Inc, Market Access & Hlth Outcome Dept, Montreal, PQ, Canada
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：350 / 350
页数：1
相关论文
共 50 条
  • [41] The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia
    Amit Mahipal
    Mark Weiss
    [J]. Current Oncology Reports, 2010, 12 : 352 - 354
  • [42] Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study
    Marinus van Oers
    Lukas Smolej
    Mario Petrini
    Fritz Offner
    Sebastian Grosicki
    Mark-David Levin
    Jaclyn Davis
    Hiya Banerjee
    Tommaso Stefanelli
    Petra Hoever
    Christian Geisler
    [J]. Blood Cancer Journal, 9
  • [43] The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia
    Mahipal, Amit
    Weiss, Mark
    [J]. CURRENT ONCOLOGY REPORTS, 2010, 12 (06) : 352 - 354
  • [44] Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study
    van Oers, Marinus
    Smolej, Lukas
    Petrini, Mario
    Offner, Fritz
    Grosicki, Sebastian
    Levin, Mark-David
    Davis, Jaclyn
    Banerjee, Hiya
    Stefanelli, Tommaso
    Hoever, Petra
    Geisler, Christian
    [J]. BLOOD CANCER JOURNAL, 2019, 9 (12)
  • [45] ANALYSIS OF THE CORRELATION OF TIME TO TREATMENT FAILURE WITH OVERALL SURVIVAL VERSUS CORRELATION OF PROGRESSION-FREE SURVIVAL WITH OVERALL SURVIVAL
    Gibson, G. D.
    Henegan, J. C.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 548 - 548
  • [46] Factors impacting progression-free survival (PFS) as a predictor of overall survival (OS)
    Stewart, David J.
    Bosse, Dominick
    Hilton, John Frederick
    Goss, Glenwood D.
    Fung-Kee-Fung, Michael
    Jonker, Derek J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [47] Prognostic Factors for Progression-free Survival and Overall Survival Αfter Recurrence of Glioblastoma
    Zemskova, Oksana
    Yu, Nathan y.
    Leppert, Jan
    Rades, Dirk
    [J]. ANTICANCER RESEARCH, 2024, 44 (07) : 3059 - 3066
  • [48] Impact of Race on Progression-Free Survival and Overall Survival in Patients with Multiple Myeloma
    Wani, Kashmira
    Gutta, Radhika
    Mittal, Aayush
    Jamil, Maria
    Springer, Kylie
    Kuriakose, Philip
    [J]. BLOOD, 2023, 142
  • [49] Bevacizumab prolongs progression-free survival but not overall survival in newly diagnosed glioblastoma
    Hemi Malkki
    [J]. Nature Reviews Neurology, 2014, 10 (4) : 179 - 179
  • [50] Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
    Beauchemin, Catherine
    Cooper, Dan
    Lapierre, Marie-Eve
    Yelle, Louise
    Lachaine, Jean
    [J]. ONCOTARGETS AND THERAPY, 2014, 7 : 1101 - 1110
12345